https://www.selleckchem.com/pr....oducts/ver155008.htm
To assess clinical predictors and outcomes associated to the need for surfactant retreatment in preterm infants. Retrospective cohort study, including very low birth weight preterm infants from January 2006 to December 2015 who underwent surfactant replacement therapy. Beractant was used (100 mg/kg), repeated every six hours if FiO2 ≥0.40. The subjects were classified into two groups single surfactant dose; and more than one dose (retreatment). We evaluated maternal and neonatal predictors for the need of retreatment and neonatal outc
Like
Comment
Share
